DRUG DISCOVERY DEVELOPMENT (DDD): PRECLINICAL TESTING

1 to ensure BIOLOGICAL ACTIVITY in vivo

2 to ensure ADEQUATE QUANTITIES OF HIGH PURITY DRUG can be made

3 to CHARACTERIZE VARIOUS CHEMICAL PROPERTIES, develop the initial drug delivery system, and DETERMINE THE STABILITY of the compound

4 to ensure LIMITED TOXICITIES of the LEAD AGENT

Question

PRECLINICAL TESTING

1 to ensure BIOLOGICAL ACTIVITY in vivo

2 to ensure ADEQUATE QUANTITIES OF HIGH PURITY DRUG can be made

3 to CHARACTERIZE VARIOUS CHEMICAL PROPERTIES, develop the initial drug delivery system, and DETERMINE THE STABILITY of the compound

4 to ensure LIMITED TOXICITIES of the LEAD AGENT

LEIGHTON DWIGHT OBILLOS · Accepted Answer

.

1 Discovery testing

2 Chemical synthesis scale-up

3 Formulation development and stability testing

4 Animal safety testing

. 1 Discovery testing 2 Chemical synthesis scale-up 3 Formulation development and stability testing 4 Animal safety testing